News

13 June 2012

Lonza and BioWa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT® CHOK1SV Cell Line for Therapeutic Antibody Development

Read full story

7 June 2012

Astute Medical Completes $40.4 Million Series C Financing

Read full story

5 June 2012

PhaseBio Pharmaceuticals Received an Additional $23 Million with Completion of the Third Tranche of a Series B Financing for Advancement of Metabolic and Cardiovascular Product Portfolio

Read full story

4 June 2012

Five Prime Therapeutics Announces that Human Genome Sciences Files U.S. IND for HGS1036/FP-1039 FGF Ligand Trap

Read full story